The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
Glaukos Corporation secures a significant FDA nod allowing repeated administration of its sustained-release iDose TR implant, broadening treatment options for patients with glaucoma and potentially reshaping long-term care paradigms.
At 77, Jane Perry's £2 million ISA portfolio stands as a testament to a simple, disciplined investment strategy begun in the 1980s. Her story challenges the gender investment gap and offers a blueprint for long-term wealth building.
A significant purchase of the Invesco BulletShares 2027 Corporate Bond ETF by BCS Wealth Management highlights a strategic move to build predictable cash flows within a multi-year portfolio, emphasizing capital preservation over speculative yield chasing.
As Amgen prepares to release its fourth-quarter results, investors are watching for signs of sustained momentum in its key drug portfolios and the impact of recent acquisitions.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
The 179-year-old tobacco giant Philip Morris International is closing its Richmond, Virginia office, eliminating 135 positions, as it aggressively restructures around its smoke-free product portfolio, led by the ZYN nicotine pouch brand.
Bayer's share price has more than doubled in the past 12 months, yet key valuation models suggest a significant gap remains between its market price and intrinsic value. We examine the metrics behind the rally and the lingering legal and portfolio challenges facing the company.
The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.
Investment firm Tanager Wealth Management has fully divested its position in Centessa Pharmaceuticals, capitalizing on the biotech's near-60% annual surge. The move highlights strategic portfolio rebalancing as the stock's rally potentially amplified its risk profile within a diversified fund.
While both ETFs target the high-flying U.S. technology sector, a closer look reveals critical distinctions in diversification, concentration risk, and liquidity that could sway long-term portfolio outcomes.
Amid a steep 60% annual share price decline, investment firm Chicago Capital has significantly reduced its position in PROCEPT BioRobotics, a developer of robotic systems for urological surgery, signaling a portfolio risk reassessment.
Danaher Corporation announces a strategic investment in Automata, aiming to integrate AI-ready automation systems with its extensive portfolio of instruments and reagents. The move signals a push to deliver comprehensive, data-driven lab solutions as the life sciences sector increasingly prioritizes efficiency and scalability.
The stablecoin issuer finished 2025 with over $10 billion in net profit, backed by a $17.4 billion gold reserve and a U.S. Treasury portfolio that rivals major nations, as demand for its USDT token continues to surge globally.
Microchip Technology expands its embedded systems portfolio with the launch of the PIC32CM PL10 microcontroller family and an enhanced maXTouch M1 touchscreen line, targeting growing demand in automotive displays and industrial automation.
Interparfums (IPAR) has locked in exclusive long-term licenses for the Nautica and David Beckham fragrance portfolios, aiming to revitalize the brands and expand their digital footprint globally. The deals signal a strategic push into mainstream lifestyle and celebrity scents.
Invesco Mortgage Capital (IVR) posted robust fourth-quarter results, buoyed by a calmer interest rate environment and outperformance in agency mortgage-backed securities. Executives detailed strategic portfolio positioning amid spread tightening and signaled cautious optimism for the year ahead.
As global travel surges past pre-pandemic records, the influx of visitors is straining infrastructure and reshaping communities worldwide. From European protests to quiet American suburbs, the quest for authentic experiences is colliding with local life, fueling a housing crisis and raising a critical question: can cities belong to both residents and tourists?
While Riverview Rubber Estates Berhad's share price has declined 12% over three years, trailing the broader market's 26% gain, its total shareholder return tells a more nuanced story. Including dividends, investors would have seen a modest 1.9% return, highlighting the critical role of income in long-term portfolio performance.
Deutsche Bank has upgraded NNN REIT to 'Buy' with a $47 price target, highlighting its defensive portfolio and sustainable dividends as relative strengths in a challenging real estate investment trust environment expected to persist through 2026.
